fashion -WSS

fashion

author：entertainment 2025-08-12 08:29:38 - browse：7

Moderna's mResvia vaccine — The FDA has approved Moderna’s RSV vaccine for older adults. Moderna

The Food and Drug Administration on Friday approved Moderna’s vaccine to protect older adults against respiratory syncytial virus, or RSV, making this the company’s second licensed product.

The Moderna RSV vaccine, which will be marketed under the name mResvia, was approved for adults 60 and older. It is made using the same messenger RNA platform as Moderna’s other licensed product, its Covid-19 vaccine Spikevax.

“The FDA approval of our second product, mResvia, builds on the strength and versatility of our mRNA platform,” Moderna CEO Stéphane Bancel said in a statement.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Do masks work? RCTs can't tell us

WSS

STAT's guide to the next generation of CAR

What would happen to your eyes if you looked at the solar eclipse?

Why are elite athletes different? Take a look at their microbes

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

CDC concerned about possible undetected monkeypox spread in U.K.

App could help diagnose ear infections more accurately — and at home

hotspot

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

What does generative AI mean for health care? We asked experts

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Guidelines to prevent youth baseball injuries need more muscle

5 to watch: Tech startups trying to solve health care's staffing crisis

United colonoscopy coverage change 'may cost lives,' doctors say

Physicians and social media: If you see something, say something?

Continuity nursing helped my family in our darkest PICU moments

#NeedHerScience: shining a light on gender disparities in medicine

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Nurses recount patients attacks

explore

Baby aspirin cuts fat buildup in liver disease patients, in small study

CDC concerned about possible undetected monkeypox spread in U.K.

The strategy behind pharma's lawsuits over drug pricing reform

Donald Trump's relentless attacks on special counsel Jack Smith

SCOTUS questions limit to govt efforts to fight misinformation

Weight bias in eating disorder treatment complicated by new weight loss drugs

hotspot

Wikipedia

entertainment

knowledge